Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Spironolactone does not increase the risk of breast cancer recurrence.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Early detection of specific skin lesions can help identify Birt-Hogg-Dube syndrome and prevent serious complications.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride use may increase the risk of male breast cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.